Literature DB >> 24206202

The effectiveness of a pneumatic compression belt in reducing respiratory motion of abdominal tumors in patients undergoing stereotactic body radiotherapy.

D Michael Lovelock1, Joan Zatcky, Karyn Goodman, Yoshiya Yamada.   

Abstract

PURPOSE: Abdominal compression using a pneumatic abdominal compression belt developed in-house has been used to reduce respiratory motion of patients undergoing hypo-fractionated or single fraction stereotactic radio-ablative therapy for abdominal cancers. The clinical objective of belt usage was to reduce the cranial-caudal (CC) respiratory motion of the tumor to 5 mm or less during both CT simulation and treatment. A retrospective analysis was done to determine the effectiveness of the device and associated clinical procedures to reduce the CC respiratory motion of the tumor.
MATERIALS AND METHODS: 42 patients treated for tumors in the liver (30), adrenal glands (6), pancreas (3) and lymph nodes (3) using high dose hypofractionated radiotherapy between 2004 and the present were eligible for analysis. All patients had 2-3 radiopaque fiducial markers implanted near the tumor prior to simulation, or had clips from prior surgery. Integral to the belt is an inflatable air bladder that is positioned over the abdomen. The pneumatic pressure was set to a level in consultation with the patient. The CC motion was measured fluoroscopically with and without pneumatic pressure. Pneumatic pressure was used at all treatments to reduce to CC motion to that achieved at simulation.
RESULTS: The mean CC motion with the belt in place, but no additional air pressure was 11.4 mm with a range of 5-20 mm. With the pressure applied, the mean CC motion was reduced to 4.4 mm with a range of 1-8 mm (P-value < 0.001). The clinical objective of reducing the CC motion of the tumor to a maximum excursion of 5 mm or less was achieved in 93% of cases.
CONCLUSION: The use of a pneumatic compression belt and associated clinical procedures was found to result in a significant and frequently substantial reduction in the CC motion of the tumor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24206202     DOI: 10.7785/tcrt.2012.500379

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  20 in total

1.  Dose escalation in the definite target volume.

Authors:  W Tyler Watkins; Hamidreza Nourzadeh; Jeffrey V Siebers
Journal:  Med Phys       Date:  2020-05-11       Impact factor: 4.071

2.  Radiobiological analysis of stereotactic body radiation therapy for an evidence-based planning target volume of the lung using multiphase CT images obtained with a pneumatic abdominal compression apparatus: a case study.

Authors:  Arun Chairmadurai; Harish Chandra Goel; Sandeep Kumar Jain; Pawan Kumar
Journal:  Radiol Phys Technol       Date:  2017-11-11

3.  Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study.

Authors:  Milly Buwenge; Savino Cilla; Alessandra Guido; Lucia Giaccherini; Gabriella Macchia; Francesco Deodato; Silvia Cammelli; Francesco Cellini; Gian C Mattiucci; Vincenzo Valentini; Markus Stock; Alessio G Morganti
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-28

4.  An evaluation of motion mitigation techniques for pancreatic SBRT.

Authors:  Warren G Campbell; Bernard L Jones; Tracey Schefter; Karyn A Goodman; Moyed Miften
Journal:  Radiother Oncol       Date:  2017-05-29       Impact factor: 6.280

Review 5.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

6.  Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors.

Authors:  Matthew L Knecht; Ning Wang; April Vassantachart; Rachel Mifflin; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2017-08

7.  Automatic assessment of average diaphragm motion trajectory from 4DCT images through machine learning.

Authors:  Guang Li; Jie Wei; Hailiang Huang; Carl Philipp Gaebler; Amy Yuan; Joseph O Deasy
Journal:  Biomed Phys Eng Express       Date:  2015-12-29

8.  Pancreatic cancer and SBRT: A new potential option?

Authors:  Carla Hajj; Karyn A Goodman
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-28

9.  Automated MV markerless tumor tracking for VMAT.

Authors:  D Ferguson; T Harris; M Shi; M Jacobson; M Myronakis; M Lehmann; P Huber; D Morf; R Fueglistaller; P Baturin; I Valencia Lozano; C Williams; R Berbeco
Journal:  Phys Med Biol       Date:  2020-06-22       Impact factor: 4.174

Review 10.  Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?

Authors:  Constantin Dreher; Daniel Habermehl; Oliver Jäkel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2017-12-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.